share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer WAGNER CHARLES F JR

福泰製藥 | 4:持股變動聲明-高管 WAGNER CHARLES F JR
美股sec公告 ·  06/05 16:18
Moomoo AI 已提取核心訊息
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Vertex Pharmaceuticals Inc致富金融(臨時代碼)的執行副總裁兼首席財務官Charles F. Wagner Jr.在2024年6月3日出售了3250股普通股,價格為每股460.00美元,總出售價值為1,495,000美元。此次交易後,Wagner在該公司的直接持股總數為47,137股普通股。該銷售是通過公開市場交易進行的,如該公司最新提交的申報所述。
Vertex Pharmaceuticals Inc致富金融(臨時代碼)的執行副總裁兼首席財務官Charles F. Wagner Jr.在2024年6月3日出售了3250股普通股,價格為每股460.00美元,總出售價值為1,495,000美元。此次交易後,Wagner在該公司的直接持股總數為47,137股普通股。該銷售是通過公開市場交易進行的,如該公司最新提交的申報所述。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息